Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local HuMax-Inflam injection for inflammatory psoriasis
2006-003252-38Phase 2Completed
- Sponsor
- Genmab
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of adakitug in psoriasis (2 arms), sponsored by Genmab. Primary endpoint: Investigator overall assessment of disease activity in treated areas. Started Aug 2006; status: completed.
02
Drugs
adakitug
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2006-003252-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003252-38.